(CRWV) CoreWeave, Common Stock - Overview
Stock: GPU, CPU, Storage, Networking, Managed
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 123% |
| Relative Tail Risk | -10.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.32 |
| Alpha | 93.95 |
| Character TTM | |
|---|---|
| Beta | 2.323 |
| Beta Downside | 2.158 |
| Drawdowns 3y | |
|---|---|
| Max DD | 64.84% |
| CAGR/Max DD | 2.41 |
Description: CRWV CoreWeave, Common Stock January 27, 2026
CoreWeave, Inc. (NASDAQ:CRWV) operates a specialized cloud platform that delivers scalable GPU- and CPU-compute, storage, networking, and managed services for generative AI workloads. Its offering includes a fleet-lifecycle controller, node-lifecycle controller, tensorizer, observability tools, and domain-specific services such as VFX rendering, AI model training, inference, and a dataset-optimization utility for machine-learning developers. The firm, incorporated in 2017 and headquartered in Livingston, New Jersey, rebranded from Atlantic Crypto Corporation in December 2019.
According to the company’s most recent Form 10-Q (Q4 2025), CoreWeave reported revenue of approximately $150 million, representing a 45 % year-over-year increase driven primarily by expanding GPU-compute contracts with enterprise AI teams. The firm now operates roughly 30,000 GPU units-a 20 % capacity growth versus the prior quarter-and maintains a gross margin of about 55 %, reflecting improved utilization and economies of scale. Cash and cash equivalents stood at roughly $200 million, providing runway for further infrastructure expansion.
The broader AI-cloud market is a key economic driver: IDC estimates a compound annual growth rate of ~30 % for AI compute services through 2028, while a persistent shortage of high-performance GPUs creates a pricing premium that benefits niche providers like CoreWeave. Competitive pressure from hyperscalers (AWS, Azure, Google Cloud) remains high, but CoreWeave’s focus on dedicated AI workloads and its “bare-metal-as-a-service” model have helped it capture a growing share of enterprise AI spend.
For a deeper, data-rich assessment of CoreWeave’s valuation dynamics, you may find ValueRay’s analytical dashboard useful.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: -766.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.24 > 0.02 and ΔFCF/TA 2.23 > 1.0 |
| NWC/Revenue: -115.7% < 20% (prev -149.2%; Δ 33.45% < -1%) |
| CFO/TA 0.05 > 3% & CFO 1.69b > Net Income -766.6m |
| Net Debt (16.91b) to EBITDA (2.21b): 7.65 < 3 |
| Current Ratio: 0.49 > 1.5 & < 3 |
| Outstanding Shares: last quarter (497.9m) vs 12m ago 14.32% < -2% |
| Gross Margin: 73.85% > 18% (prev 0.73%; Δ 7312 % > 0.5%) |
| Asset Turnover: 18.31% > 50% (prev 9.08%; Δ 9.22% > 0%) |
| Interest Coverage Ratio: 0.21 > 6 (EBITDA TTM 2.21b / Interest Expense TTM 990.4m) |
Altman Z'' -1.23
| A: -0.15 (Total Current Assets 4.73b - Total Current Liabilities 9.71b) / Total Assets 32.91b |
| B: -0.07 (Retained Earnings -2.19b / Total Assets 32.91b) |
| C: 0.01 (EBIT TTM 212.9m / Avg Total Assets 23.52b) |
| D: -0.08 (Book Value of Equity -2.19b / Total Liabilities 29.03b) |
| Altman-Z'' Score: -1.23 = CCC |
Beneish M -1.41
| DSRI: 0.99 (Receivables 1.66b/498.8m, Revenue 4.31b/1.28b) |
| GMI: 0.99 (GM 73.85% / 73.05%) |
| AQI: 1.04 (AQ_t 0.09 / AQ_t-1 0.08) |
| SGI: 3.35 (Revenue 4.31b / 1.28b) |
| TATA: -0.07 (NI -766.6m - CFO 1.69b) / TA 32.91b) |
| Beneish M-Score: -1.41 (Cap -4..+1) = D |
What is the price of CRWV shares?
Over the past week, the price has changed by +1.14%, over one month by +16.68%, over three months by -14.83% and over the past year by +124.88%.
Is CRWV a buy, sell or hold?
- StrongBuy: 5
- Buy: 2
- Hold: 9
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the CRWV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 127.2 | 41.4% |
| Analysts Target Price | 127.2 | 41.4% |
| ValueRay Target Price | 90.5 | 0.6% |
CRWV Fundamental Data Overview February 04, 2026
P/B = 13.3781
Revenue TTM = 4.31b USD
EBIT TTM = 212.9m USD
EBITDA TTM = 2.21b USD
Long Term Debt = 10.32b USD (from longTermDebt, last quarter)
Short Term Debt = 4.11b USD (from shortTermDebt, last quarter)
Debt = 18.81b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.91b USD (from netDebt column, last quarter)
Enterprise Value = 63.23b USD (46.36b + Debt 18.81b - CCE 1.94b)
Interest Coverage Ratio = 0.21 (Ebit TTM 212.9m / Interest Expense TTM 990.4m)
EV/FCF = -7.84x (Enterprise Value 63.23b / FCF TTM -8.06b)
FCF Yield = -12.75% (FCF TTM -8.06b / Enterprise Value 63.23b)
FCF Margin = -187.2% (FCF TTM -8.06b / Revenue TTM 4.31b)
Net Margin = -17.80% (Net Income TTM -766.6m / Revenue TTM 4.31b)
Gross Margin = 73.85% ((Revenue TTM 4.31b - Cost of Revenue TTM 1.13b) / Revenue TTM)
Gross Margin QoQ = 72.97% (prev 74.22%)
Tobins Q-Ratio = 1.92 (Enterprise Value 63.23b / Total Assets 32.91b)
Interest Expense / Debt = 1.65% (Interest Expense 310.6m / Debt 18.81b)
Taxrate = 21.0% (US default 21%)
NOPAT = 168.2m (EBIT 212.9m * (1 - 21.00%))
Current Ratio = 0.49 (Total Current Assets 4.73b / Total Current Liabilities 9.71b)
Debt / Equity = 4.85 (Debt 18.81b / totalStockholderEquity, last quarter 3.88b)
Debt / EBITDA = 7.65 (Net Debt 16.91b / EBITDA 2.21b)
Debt / FCF = -2.10 (negative FCF - burning cash) (Net Debt 16.91b / FCF TTM -8.06b)
Total Stockholder Equity = 2.59b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.26% (Net Income -766.6m / Total Assets 32.91b)
RoE = -29.62% (Net Income TTM -766.6m / Total Stockholder Equity 2.59b)
RoCE = 1.65% (EBIT 212.9m / Capital Employed (Equity 2.59b + L.T.Debt 10.32b))
RoIC = 1.29% (NOPAT 168.2m / Invested Capital 13.02b)
WACC = 10.68% (E(46.36b)/V(65.17b) * Re(14.48%) + D(18.81b)/V(65.17b) * Rd(1.65%) * (1-Tc(0.21)))
Discount Rate = 14.48% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 11.05%
Fair Price DCF = unknown (Cash Flow -8.06b)
EPS Correlation: 4.22 | EPS CAGR: -13.47% | SUE: N/A | # QB: 0
Revenue Correlation: 95.47 | Revenue CAGR: 309.0% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.52 | Chg30d=+0.061 | Revisions Net=+1 | Analysts=9
EPS next Year (2026-12-31): EPS=-1.39 | Chg30d=+0.023 | Revisions Net=+1 | Growth EPS=+46.1% | Growth Revenue=+136.0%